Search

Search results

Current filters: Hepatitis C drugs, Hepatitis C, Treatment, Research summary

40 search results

Large review from three French studies finds no link between use of DAAs and recurrence of liver cancer

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Bologna researchers find no link between DAAs and liver cancer

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Vienna doctors urge caution when assessing possible associations between liver cancer recurrence and use of DAAs

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Barcelona: Reports of unexpected cases of liver cancer in people undergoing treatment with DAAs

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Looking back at liver cancer rates among people who received interferon therapy

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Caution needed about claims of increased risk of liver cancer recurrence with use of DAAs

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

DAAs found highly tolerable (and effective) in people with mental health conditions

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

The looming arrival of Epclusa – sofosbuvir + velpatasvir

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

ABT-493 + ABT-530 in genotype 1 with previous DAA therapy failure

From TreatmentUpdate 215
2016, CATIE
Research summary - Webpage

ABT-493 + ABT-530 in genotypes 4, 5 and 6

From TreatmentUpdate 215
2016, CATIE
Research summary - Webpage